Kindly MD, Inc.
Kindly MD, Inc. (KDLY) Stock Competitors & Peer Comparison
See (KDLY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Equipment & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KDLY | $11.30 | +1.16% | 68.1M | -15.48 | -$0.73 | N/A |
| SIRO | $109.97 | +0.00% | 22B | N/A | N/A | N/A |
| HIMS | $22.29 | -11.02% | 4.9B | -247.67 | -$0.09 | N/A |
| NVST | $23.15 | -0.30% | 3.8B | 56.44 | $0.41 | N/A |
| NAKA | $0.17 | -9.33% | 3.4B | -0.37 | -$0.47 | N/A |
| CON | $26.08 | +0.81% | 3.3B | 18.76 | $1.39 | +0.95% |
| BBNX | $9.40 | -0.63% | 418.9M | -6.86 | -$1.37 | N/A |
| CV | $6.36 | -1.47% | 317.8M | -6.00 | -$1.06 | N/A |
| NEUE | $6.75 | +0.00% | 60.9M | -0.38 | -$17.65 | N/A |
| PARK | $18.50 | +2.04% | 35.8M | -102.31 | -$0.18 | N/A |
Stock Comparison
KDLY vs SIRO Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, SIRO has a market cap of 22B. Regarding current trading prices, KDLY is priced at $11.30, while SIRO trades at $109.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas SIRO's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to SIRO's ROE of +0.14%. Regarding short-term risk, KDLY is more volatile compared to SIRO. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check SIRO's competition here
KDLY vs HIMS Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, HIMS has a market cap of 4.9B. Regarding current trading prices, KDLY is priced at $11.30, while HIMS trades at $22.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas HIMS's P/E ratio is -247.67. In terms of profitability, KDLY's ROE is -0.85%, compared to HIMS's ROE of -0.02%. Regarding short-term risk, KDLY is less volatile compared to HIMS. This indicates potentially lower risk in terms of short-term price fluctuations for KDLY.Check HIMS's competition here
KDLY vs NVST Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, NVST has a market cap of 3.8B. Regarding current trading prices, KDLY is priced at $11.30, while NVST trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas NVST's P/E ratio is 56.44. In terms of profitability, KDLY's ROE is -0.85%, compared to NVST's ROE of +0.02%. Regarding short-term risk, KDLY is more volatile compared to NVST. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check NVST's competition here
KDLY vs NAKA Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, NAKA has a market cap of 3.4B. Regarding current trading prices, KDLY is priced at $11.30, while NAKA trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas NAKA's P/E ratio is -0.37. In terms of profitability, KDLY's ROE is -0.85%, compared to NAKA's ROE of -0.85%. Regarding short-term risk, KDLY is less volatile compared to NAKA. This indicates potentially lower risk in terms of short-term price fluctuations for KDLY.Check NAKA's competition here
KDLY vs CON Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, CON has a market cap of 3.3B. Regarding current trading prices, KDLY is priced at $11.30, while CON trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas CON's P/E ratio is 18.76. In terms of profitability, KDLY's ROE is -0.85%, compared to CON's ROE of +0.46%. Regarding short-term risk, KDLY is more volatile compared to CON. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check CON's competition here
KDLY vs BBNX Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, BBNX has a market cap of 418.9M. Regarding current trading prices, KDLY is priced at $11.30, while BBNX trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas BBNX's P/E ratio is -6.86. In terms of profitability, KDLY's ROE is -0.85%, compared to BBNX's ROE of -0.23%. Regarding short-term risk, KDLY is less volatile compared to BBNX. This indicates potentially lower risk in terms of short-term price fluctuations for KDLY.Check BBNX's competition here
KDLY vs CV Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, CV has a market cap of 317.8M. Regarding current trading prices, KDLY is priced at $11.30, while CV trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas CV's P/E ratio is -6.00. In terms of profitability, KDLY's ROE is -0.85%, compared to CV's ROE of +1.27%. Regarding short-term risk, KDLY is less volatile compared to CV. This indicates potentially lower risk in terms of short-term price fluctuations for KDLY.Check CV's competition here
KDLY vs NEUE Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, NEUE has a market cap of 60.9M. Regarding current trading prices, KDLY is priced at $11.30, while NEUE trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas NEUE's P/E ratio is -0.38. In terms of profitability, KDLY's ROE is -0.85%, compared to NEUE's ROE of +0.09%. Regarding short-term risk, KDLY is more volatile compared to NEUE. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check NEUE's competition here
KDLY vs PARK Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, PARK has a market cap of 35.8M. Regarding current trading prices, KDLY is priced at $11.30, while PARK trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas PARK's P/E ratio is -102.31. In terms of profitability, KDLY's ROE is -0.85%, compared to PARK's ROE of -0.00%. Regarding short-term risk, KDLY is more volatile compared to PARK. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check PARK's competition here
KDLY vs BRK Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, BRK has a market cap of 11.6M. Regarding current trading prices, KDLY is priced at $11.30, while BRK trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas BRK's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to BRK's ROE of N/A. Regarding short-term risk, KDLY is more volatile compared to BRK. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check BRK's competition here
KDLY vs PFSA Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, PFSA has a market cap of 243K. Regarding current trading prices, KDLY is priced at $11.30, while PFSA trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas PFSA's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to PFSA's ROE of +0.82%. Regarding short-term risk, KDLY is less volatile compared to PFSA. This indicates potentially lower risk in terms of short-term price fluctuations for KDLY.Check PFSA's competition here
KDLY vs SPNC Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, SPNC has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while SPNC trades at $38.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas SPNC's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to SPNC's ROE of -0.61%. Regarding short-term risk, KDLY is more volatile compared to SPNC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check SPNC's competition here
KDLY vs MZOR Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, MZOR has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while MZOR trades at $58.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas MZOR's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to MZOR's ROE of -0.14%. Regarding short-term risk, KDLY is more volatile compared to MZOR. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check MZOR's competition here
KDLY vs PMC Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, PMC has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while PMC trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas PMC's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to PMC's ROE of +0.04%. Regarding short-term risk, KDLY is more volatile compared to PMC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check PMC's competition here
KDLY vs SCAI Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, SCAI has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while SCAI trades at $55.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas SCAI's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to SCAI's ROE of +0.09%. Regarding short-term risk, KDLY is more volatile compared to SCAI. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check SCAI's competition here
KDLY vs STJ Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, STJ has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while STJ trades at $80.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas STJ's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to STJ's ROE of +0.21%. Regarding short-term risk, KDLY is more volatile compared to STJ. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check STJ's competition here
KDLY vs DSCI Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, DSCI has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while DSCI trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas DSCI's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to DSCI's ROE of -0.00%. Regarding short-term risk, KDLY is more volatile compared to DSCI. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check DSCI's competition here
KDLY vs AMSG Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, AMSG has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while AMSG trades at $67.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas AMSG's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to AMSG's ROE of +0.08%. Regarding short-term risk, KDLY is more volatile compared to AMSG. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check AMSG's competition here
KDLY vs SPAN Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, SPAN has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while SPAN trades at $29.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas SPAN's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to SPAN's ROE of +0.17%. Regarding short-term risk, KDLY is less volatile compared to SPAN. This indicates potentially lower risk in terms of short-term price fluctuations for KDLY.Check SPAN's competition here
KDLY vs EXAC Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, EXAC has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while EXAC trades at $49.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas EXAC's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to EXAC's ROE of +0.00%. Regarding short-term risk, KDLY is more volatile compared to EXAC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check EXAC's competition here
KDLY vs ABAX Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, ABAX has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while ABAX trades at $83.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas ABAX's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to ABAX's ROE of +0.10%. Regarding short-term risk, KDLY is more volatile compared to ABAX. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check ABAX's competition here
KDLY vs COTV Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, COTV has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while COTV trades at $44.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas COTV's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to COTV's ROE of +0.14%. Regarding short-term risk, KDLY is more volatile compared to COTV. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check COTV's competition here
KDLY vs LDR Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, LDR has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while LDR trades at $67.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas LDR's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to LDR's ROE of +1.17%. Regarding short-term risk, KDLY is more volatile compared to LDR. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check LDR's competition here
KDLY vs LPNT Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, LPNT has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while LPNT trades at $64.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas LPNT's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to LPNT's ROE of +0.05%. Regarding short-term risk, KDLY is more volatile compared to LPNT. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check LPNT's competition here
KDLY vs MEDC Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, MEDC has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while MEDC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas MEDC's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to MEDC's ROE of N/A. Regarding short-term risk, KDLY is less volatile compared to MEDC. This indicates potentially lower risk in terms of short-term price fluctuations for KDLY.Check MEDC's competition here
KDLY vs EVHC Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, EVHC has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while EVHC trades at $45.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas EVHC's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to EVHC's ROE of +0.07%. Regarding short-term risk, KDLY is more volatile compared to EVHC. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check EVHC's competition here
KDLY vs ABCO Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, ABCO has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while ABCO trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas ABCO's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to ABCO's ROE of +0.19%. Regarding short-term risk, KDLY is more volatile compared to ABCO. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check ABCO's competition here
KDLY vs CYNO Comparison May 2026
KDLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KDLY stands at 68.1M. In comparison, CYNO has a market cap of 0. Regarding current trading prices, KDLY is priced at $11.30, while CYNO trades at $66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KDLY currently has a P/E ratio of -15.48, whereas CYNO's P/E ratio is N/A. In terms of profitability, KDLY's ROE is -0.85%, compared to CYNO's ROE of +0.03%. Regarding short-term risk, KDLY is more volatile compared to CYNO. This indicates potentially higher risk in terms of short-term price fluctuations for KDLY.Check CYNO's competition here